These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31613797)
21. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223 [TBL] [Abstract][Full Text] [Related]
22. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900 [TBL] [Abstract][Full Text] [Related]
23. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
24. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization. Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479 [TBL] [Abstract][Full Text] [Related]
25. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701 [TBL] [Abstract][Full Text] [Related]
26. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing. Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822 [TBL] [Abstract][Full Text] [Related]
27. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein. Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425 [TBL] [Abstract][Full Text] [Related]
28. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686 [TBL] [Abstract][Full Text] [Related]
29. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease. Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo. Akiyama H; Tanaka T; Itakura H; Kanai H; Maeno T; Doi H; Yamazaki M; Takahashi K; Kimura Y; Kishi S; Kurabayashi M Invest Ophthalmol Vis Sci; 2004 May; 45(5):1289-96. PubMed ID: 15111579 [TBL] [Abstract][Full Text] [Related]
31. Distinct patterns of expression of the RB gene family in mouse and human retina. Spencer C; Pajovic S; Devlin H; Dinh QD; Corson TW; Gallie BL Gene Expr Patterns; 2005 Jun; 5(5):687-94. PubMed ID: 15939381 [TBL] [Abstract][Full Text] [Related]
32. [Von Hippel-Lindau syndrome - a case report]. Figlus M; Kaczorowska B; Jaskólski DJ; Kępczyński Ł Pol Merkur Lekarski; 2018 May; 44(263):248-252. PubMed ID: 29813043 [TBL] [Abstract][Full Text] [Related]
33. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE. Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528 [TBL] [Abstract][Full Text] [Related]
35. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor. Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597 [TBL] [Abstract][Full Text] [Related]
36. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612 [TBL] [Abstract][Full Text] [Related]
37. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms. Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300 [TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease. Wittström E; Nordling M; Andréasson S Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745 [TBL] [Abstract][Full Text] [Related]
39. Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Lange C; Caprara C; Tanimoto N; Beck S; Huber G; Samardzija M; Seeliger M; Grimm C Neurobiol Dis; 2011 Jan; 41(1):119-30. PubMed ID: 20817091 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]